Skip to main content
Frontiers in Microbiology logoLink to Frontiers in Microbiology
. 2015 Dec 2;6:1373. doi: 10.3389/fmicb.2015.01373

Phenotypic Heterogeneity Affects Stenotrophomonas maltophilia K279a Colony Morphotypes and β-Lactamase Expression

Ebrahim M Abda 1, Dagmar Krysciak 1, Ines Krohn-Molt 1, Uwe Mamat 2, Christel Schmeisser 1, Konrad U Förstner 3, Ulrich E Schaible 4, Thomas A Kohl 4, Stefan Nieman 4,5, Wolfgang R Streit 1,*
PMCID: PMC4667094  PMID: 26696982

Abstract

Phenotypic heterogeneity at the cellular level in response to various stresses, e.g., antibiotic treatment has been reported for a number of bacteria. In a clonal population, cell-to-cell variation may result in phenotypic heterogeneity that is a mechanism to survive changing environments including antibiotic therapy. Stenotrophomonas maltophilia has been frequently isolated from cystic fibrosis patients, can cause numerous infections in other organs and tissues, and is difficult to treat due to antibiotic resistances. S. maltophilia K279a produces the L1 and L2 β-lactamases in response to β-lactam treatment. Here we report that the patient isolate S. maltophilia K279a diverges into cellular subpopulations with distinct but reversible morphotypes of small and big colonies when challenged with ampicillin. This observation is consistent with the formation of elongated chains of bacteria during exponential growth phase and the occurrence of mainly rod-shaped cells in liquid media. RNA-seq analysis of small versus big colonies revealed differential regulation of at least seven genes among the colony morphotypes. Among those, blaL1 and blaL2 were transcriptionally the most strongly upregulated genes. Promoter fusions of blaL1 and blaL2 genes indicated that expression of both genes is also subject to high levels of phenotypic heterogeneous expression on a single cell level. Additionally, the comE homolog was found to be differentially expressed in homogenously versus heterogeneously blaL2 expressing cells as identified by RNA-seq analysis. Overexpression of comE in S. maltophilia K279a reduced the level of cells that were in a blaL2-ON mode to 1% or lower. Taken together, our data provide strong evidence that S. maltophilia K279a populations develop phenotypic heterogeneity in an ampicillin challenged model. This cellular variability is triggered by regulation networks including blaL1, blaL2, and comE.

Keywords: phenotypic heterogeneity, Stenotrophomonas maltophilia, K279a, β-lactamases, colony morphotypes, antibiotic resistance, RNA-seq

Introduction

Stenotrophomonas maltophilia is a Gram-negative, non-fermentative bacterium, which is usually associated with the rhizosphere but can cause opportunistic infections of the respiratory tract in immunocompromised patients. In recent years, S. maltophilia has been frequently isolated from cystic fibrosis patient. As a nosocomial pathogen, it can also cause numerous infections in other organs and tissues, including bacteremia, endocarditis, pneumonia, peritonitis, cellulitis, and meningitis (Agger et al., 1986; Elting and Bodey, 1990; Nguyen and Muder, 1994; Gutierrez Rodero et al., 1996; Elsner et al., 1997; Al-Hilali et al., 2000). Treatment is often difficult because the microorganism is intrinsically resistant against many common antibiotics including β-lactams (Denton and Kerr, 1998; Crossman et al., 2008; Ryan et al., 2009; Brooke, 2012). The intrinsic resistance of S. maltophilia K279a (SMK279a) against β-lactam antibiotics is primarily due to the function of two β-lactam resistance genes, blaL1 (smlt2667) and blaL2 (smlt3722), (Saino et al., 1982; Walsh et al., 1994, 1997). The product of blaL1 is an Ambler class B Zn+-dependent metalloenzyme, and the product of blaL2 is an Ambler class A serine active site β-lactamase. Both enzymes are responsible for inactivation of a wide range of different β-lactam antibiotics (Walsh et al., 1994, 1997; Al Naiemi et al., 2006).

Expression of blaL1 and blaL2, which is controlled by the activities of several proteins including AmpG, NagZ, AmpD, and the transcriptional regulator AmpR (Cullmann and Dick, 1990; Avison et al., 2002; Gould et al., 2006; Hu et al., 2008; Okazaki and Avison, 2008), has been suggested to be induced by β-lactam antibiotics. Furthermore, the expression of β-lactam resistance genes is linked to cell wall biosynthesis, a complex dynamic process affected by multiple cellular processes such as growth phase, division cycle, quorum sensing, and cell stress (Typas et al., 2012; Zeng and Lin, 2013). In addition to its autoregulation of transcription, AmpR regulates the induction of chromosomal β-lactamases in Gram-negative bacteria (Balcewich et al., 2010). A homologous ampR-blaL2 module with a similar induction mechanism has been identified earlier in S. maltophilia (Lin et al., 2009). In this bacterium, ampR (smlt3723) is physically linked to blaL2, and it is assumed that AmpR can also regulate the expression of the unlinked blaL1 gene (Okazaki and Avison, 2008). In the absence of an inducer, AmpR maintains its inactive conformational state as a result of binding to effector molecules, i.e., UDP-MurNAc-oligopeptides. However, exposure of the bacteria to β-lactam antibiotics increases cytosolic accumulation of anhydro-MurNAc-oligopeptides, a cell wall degradation product, which can displace the AmpR-associated UDP-MurNAc-oligopeptides. This leads to a conformational change of AmpR and subsequent activation of blaL1 and blaL2 transcription (Dietz et al., 1997; Jacobs et al., 1997; Balcewich et al., 2010).

While it is well known that the genetic background determines the ability of a bacterial strain to overcome antibiotic stress, bacteria have developed additional mechanisms to successfully overcome antibiotic treatment. These mechanisms may include smaller genetic variations such as single nucleotide polymorphisms (SNPs) and non-genetic variations. Within this context, phase variations can also be the cause of antibiotic resistance and/or phenotype switching. They occur at a rate of 1:10,000 in a population and can be the result of different events (Henderson and Owen, 1999; Tipton et al., 2015; and references herein).

Non-genetic variations that exist within an isogenic population contribute to the survival and fitness of the population (Ackermann, 2015; Grote et al., 2015). In a clonal population, cell-to-cell variation may result in a measurable phenotype termed phenotypic heterogeneity (Kaern et al., 2005; Magdanova and Golyasnaya, 2013). Phenotypic heterogeneity via heterogeneous gene expression benefits the population through division of labor and bet-hedging in a homogeneous environment as represented by laboratory culture conditions. This has been demonstrated for a number of model organisms such as Salmonella enterica serovar Typhimurium, Vibrio harveyi, Bacillus subtilis, Sinorhizobium fredii, and others (Anetzberger et al., 2009; Deris et al., 2013; Mulder and Coombes, 2013; Grote et al., 2014; Wang et al., 2014). Therefore, phenotypic heterogeneity is a way of multicellularity in bacterial populations to enhance the ability to adapt to changing environments (Shapiro, 1998; Davidson and Surette, 2008) and, consequently needs to be better understood to optimize antibiotic treatment strategies.

It has been shown that some bacteria can survive an antibiotic treatment by stochastically entering a dormant persister state during vegetative growth. The persister cells form transiently antibiotic tolerant subpopulations susceptible to re-introduction of the antibiotic stress, indicating that non-genetic mechanisms are involved in this process (Lewis, 2007, 2010). Much research has been focused on the exploration of the molecular keys linked to the persister phenomenon. For a more detailed insight into this topic, we refer to the excellent reviews given in references (Lewis, 2010; Helaine and Kugelberg, 2014; Maisonneuve and Gerdes, 2014). The persister phenotype depends on various factors such as the level of signaling nucleotide (p)ppGpp, and various metabolic activities (Maisonneuve et al., 2013; Amato et al., 2014). Thereby it is well accepted that toxin–antitoxin (TA) systems play a key role in the regulatory network of persisters. These systems consist of a ‘toxin’, which is normally a stable protein that interferes with vital cellular functions and a cognate ‘antitoxin’, an unstable protein or RNA molecule, which regulates the toxin level. The most prominent example for a TA system controlling persistence is the Escherichia coli hipAB TA system. However, additional systems have been described and ranked in the order of their importance (Keren et al., 2004; Lewis, 2007; Wu et al., 2015).

Here we report phenotypic heterogeneity in SMK279a upon exposure to β-lactam antibiotics. SMK279a was isolated from a blood sample of a hospitalized patient and has a genome size of 4,851,126 bp (Crossman et al., 2008). In the presence of ampicillin, SMK279a cells showed heterogeneity in colony and cell morphology, which goes along with colony-specific patterns of differentially expressed genes, including expression of the β-lactam resistance genes blaL1 and blaL2. As demonstrated with reporter gene fusions, blaL1 and blaL2 are subject to differential regulation even at the single cell level. Together with genome-wide sequences of cells from the different colony morphotypes, our data show that phenotypic heterogeneity in S. maltophilia K279a is a result of non-genetic variations in individual cells within isogenic populations.

Materals And Methods

Bacterial Strains, Plasmids, and Growth Conditions

All strains and plasmids used in the present study are described in Table 1. S. maltophilia and E. coli strains were routinely grown either in LB medium (10 g/l tryptone, 5 g/l yeast extract and 5 g/l NaCl) or on LB agar plates at 30 or 37°C. Ampicillin (100 μg/ml), gentamicin (10 μg/ml), kanamycin (25 μg/ml), chloramphenicol (60 μg/ml), norfloxacin (5 μg/ml), or tetracycline (50 μg/ml) was added to the media as required. For analyses of phenotypic colony heterogeneity, SMK279a was spread on LB agar plates without or with ampicillin (100 μg/ml) and incubated at 37°C for 48 h. Pre-cultures were grown in 5 ml test tubes at 37°C. For analysis of single cell expression, cultures were grown for 12 to 15 generations in LB broth supplemented with gentamicin (50 μg/ml) and without β-lactam inducer. The Minimal Inhibitory Concentration (MIC) for ampicillin was analyzed using the microdilution technique and found to be at a level of 254 μg/ml.

Table 1.

Bacterial strains and plasmids used in this work.

Strain or construct Description Reference
Escherichia coli strains
HB101 F-, hsdS20(rB-mB-), recA13, ara14, proA2, lacY1, galK2,rpsL20 (SmR) xyl-5, mtl-1, supE44, λ-, Figurski and Helinski, 1979
SY327 Δ(lac pro) argE(Am) recA56 rif R nalAλ pir Miller and Mekalanos, 1988
DH5α F- Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17(rK- mK+) phoA supE44 thi-1 gyrA96 relA1λ- Hanahan, 1983
Stenotrophomonas maltophilia strains
SMK279a Clinical isolate from the blood of a cancer patient Avison et al., 2000
SMK279aΔsmlt1134 SMK279a lacking the smlt1134 gene coding for a putative DNA transport competence protein This study
SMK279aΔsmlt2851Δ smlt2852 SMK279a lacking the smlt2851 and smlt2852 genes coding for putative transmembrane efflux proteins This study
SMK279aΔsmlt3723 SMK279a lacking the ampR (smlt3723) gene; a putative HTH and LysR family transcriptional regulator This study
SMK279aΔsmlt0387 SMK279a carrying a deletion in smlt0387 This study
SMK279a EM2 SMK279a carrying pBBR1MCS-5::PblaL2::rfp This study
SMK279a EM3 SMK279a carrying pBBR1MCS-5::PblaL1::rfp This study
SMK279a EM4 SMK279a carrying pBBR1MCS-5::Pless::rfp This study
SMK279a EM5 SMK279a carrying pBBR1MCS-5::PblaL2::cfp This study
SMK279a EM6 SMK279a carrying pBBR1MCS-5::PblaL2::yfp This study
SMK279a EM7 SMK279a carrying pBBR1MCS-5::PblaL2s::rfp This study
SMK279a EM8 SMK279a carrying pBBR1MCS-5::PblaL2::rfp::smlt1134 This study
SMK279a EM9 SMK279a carrying pBBR1MCS-5::PblaL2::rfp:: smlt2851::smlt2852 This study
CF148 Clinical isolate from the respiratory tract of a cystic fibrosis patient Jörg Steinmann (Universitätsklinikum Essen)
DSM-50170 Reference strain from the oropharyngeal region of a patient with cancer Leibniz institute DSMZ
Plasmids
pRK2013 KanR; RK2-derived helper plasmid carrying the tra and mob genes for mobilization of plasmids containing oriT Figurski and Helinski, 1979
pBBR1MCS-5 Broad host range vector, low copy, Gmr Kovach et al., 1995
pBBR1MCS-5::rfp pBBR1MCS-5 carrying the rfp gene in the MCS This study
pBBR1MCS-5::PblaL1::rfp PblaL2::rfp reporter fusion in pBBR1MCS-5 This study
pBBR1MCS-5::PblaL2::rfp PblaL1::rfp reporter fusion in pBBR1MCS-5 This study
pBBR1MCS-5::PblaL2::yfp PblaL2::yfp reporter fusion in pBBR1MCS-5 This study
pBBR1MCS-5::PblaL2::cfp PblaL2::cfp reporter fusion in pBBR1MCS-5 This study
pBBR1MCS-5::Pless::rfp Promoterless rfp reporter fusion in pBBR1MCS-5 This study
pBBR1MCS-5::PblaL2s::rfp PblaL2s::rfp reporter fusion constructed with the ampR-blaL2 intergenic region in pBBR1MCS-5 This study
pBBR1MCS-5:: PblaL2::rfp::smlt1134 smlt1134 gene under its native promoter cloned into the pBBR1MCS-5::PblaL2::rfp reporter fusion This study
pBBR1MCS-5::PblaL2::rfp:: smlt2851::smlt2852 Putative operon of smlt2851 and smlt2852 under its native promoter cloned into the pBBR1MCS-5::PblaL2::rfp reporter fusion This study
pGPI-SceI-XCm CmR, TpR; mobilizable suicide vector; carries the R6Kγ origin of replication, the I-SceI recognition site and a xylE reporter gene Hamad et al., 2010
pDAI-SceI-SacB TetR; mobilizable broad host range plasmid; carries the gene for the I-SceI homing endonuclease and the sacB gene Flannagan et al., 2008; Hamad et al., 2010
pUDK011 pGPI-SceI-XCm with a 705-bp SphI/KpnI insert of SMK279a containing the flanking region upstream of smlt1134 This study
pUDK012 pUDK011with a 741-bp KpnI/XbaI insert of SMK279a containing the flanking region downstream of smlt1134 This study
pUDK014 pGPI-SceI-XCm with a 779-bp NotI/KpnI insert of SMK279a containing the flanking region upstream of smlt2852 This study
pUDK015 pUDK014 with a 776-bp KpnI/XbaI insert of SMK279a containing the flanking region downstream of smlt2851 This study
pUDK017 pGPI-SceI-XCm with a 761-bp NotI/KpnI insert of SMK279a containing the flanking region upstream of smlt3723 This study
pUDK018 pUDK017 with a 660-bp KpnI/XbaI insert of SMK279a containing the flanking region downstream of smlt3723 This study

Scanning and Fluorescence Microscopy

Scanning electron microscopy (SEM) was performed as previously published (Krohn-Molt et al., 2013). Therefore, bacterial cells were grown overnight in 5 ml LB broth or on LB agar plates for 48 h. The cell suspension was centrifuged at 13,000 rpm for 2 min. The pellets or the colonies were resuspended in 500 μl sterile PBS-buffer, fixed in paraformaldehyde (1%) and glutaraldehyde (0.25%) and dehydrated gradually after successive immersions in ethanol solutions of increasing concentrations (30, 50, 70, 90, and 96%). Each rinsing and dehydrating step lasted 10 min. Finally, cells were dehydrated overnight in absolute ethanol (99.6%). The drying step was completed by drying pelletized cells at the critical point with the Balzers CPD 030 Critical Point Dryer. After coating samples with gold using an SCD 050 sputter coater (Bal-Tec), scanning electron micrographs were taken with a Leo 1525 (Zeiss, Germany).

Single cell analyses were evaluated as previously described (Grote et al., 2014). The phase-contrast and fluorescence images were recorded using a Zeiss AxioCam microscope with an MRm camera mounted on the fluorescence microscope (Zeiss Axio Imager.M2; Carl Zeiss AG, Oberkochen, Germany). For fluorescence imaging, the microscope was equipped with filter BP546/12 (red), the emission filter 605/75 (red), and a Zeiss Illuminator HXP 120 C. Phase-contrast and fluorescence images were obtained from the same area and matched using the Axio-Vision software (release 4.8). The fluorescence phenotypes of single cells were recorded by evaluating, in general, a minimum of 400 cells per biological sample. For each treatment, at least three independent samples were analyzed by visually inspecting the obtained images.

Molecular Cloning and Generation of SMK279a Mutants

For construction of the reporter gene fusions, the genes rfp (DsRed2; Baird et al., 2000), cfp (mCerulean; Rizzo et al., 2004) and yfp (mVenus; Shaner et al., 2004) were fused to DNA fragments carrying the promoter of the blaL1 gene or the promoter and intergenic region of the blaL2 gene. The DNA fragments containing the promoter region were 318 bp for blaL2, the intergenic region 180 bp for blaL2 and 417 bp for blaL1, and were predicted using PromBase (Rangannan and Bansal, 2011). These cassettes were cloned into the broad host range vector pBBR1MCS-5 (Kovach et al., 1995). Constructs were verified by DNA sequencing. The recombinant plasmids were transferred to SMK279a by triparental mating, using E. coli HB101 carrying the plasmid pRK2013 as a helper strain (Figurski and Helinski, 1979).

Markerless SMK279a mutants were constructed using the pGPI-SceI/pDAI-SceI-SacB system originally developed for bacteria of the genus Burkholderia (Flannagan et al., 2008; Aubert et al., 2014). The bacterial strains and plasmids of the pGPI-SceI/pDAI-SceI-SacB system were a generous gift from Miguel A. Valvano (Center for Infection and Immunity, Queen’s University, Belfast, UK). The mutagenesis method is based on the I-SceI homing endonuclease system, which relies on two independent crossover events to integrate first a deletion plasmid with a I-SceI recognition site into the genome of the recipient and then resolve the co-integrate structure by a second homologous recombination event in the presence of the I-SceI endonuclease provided in trans on plasmid pDAI-SceI-SacB. The deletion plasmid was derived from the mobilizable suicide vector pGPI-SceI-XCm and contained upstream and downstream flanking regions of the gene to be deleted. All deletion plasmids were generated and maintained in E. coli SY327 (Miller and Mekalanos, 1988), which constitutively expresses the λ pir gene product for replication of plasmids containing the R6Kγ origin of replication such as pGPI-SceI-XCm. To construct the deletion plasmid pUDK012 targeting the smlt1134 gene of SMK279a, the primers KOsmlt1134-1, and KOsmlt1134-2 (Table 2) were used to amplify a 705 bp fragment of the flanking region upstream of smlt1134, followed by digestion of the PCR product with SphI/KpnI and cloning into the SphI/KpnI sites of pGPI-SceI-XCm. The resulting plasmid was designated pUDK011. The flanking downstream region of smlt1134 of 741 bp was obtained by PCR with primer pair KOsmlt1134-3/KOsmlt1134-4. The PCR product was then digested with KpnI/XbaI and cloned into the KpnI/XbaI sites of pUDK011 to yield pUDK012. For deletion of the genomic region containing the smlt2852 and smlt2851 genes, the plasmid pUDK015 was constructed. As a first step, the plasmid pUDK014 was generated by amplification of the flanking upstream region of smlt2852 with primers KOsmlt2852-1 and KOsmlt2852-2, digestion of the PCR product with NotI/KpnI and ligation of the 779 bp insert into the NotI/KpnI sites of pGPI-SceI-XCm. The primer pair KOsmlt2851-3/KOsmlt2851-4 was subsequently used to amplify a 776 bp fragment containing the flanking downstream sequences of smlt2851, followed by cloning of the KpnI- and XbaI-digested PCR product into the KpnI/XbaI sites of pUDK014 to yield the deletion plasmid pUDK015.

Table 2.

Primers used in this study.

Primer Sequence [5′-3′]
Smlt3722For CTTAGGTACCCGGATCTGGTGGCTCAGT
Smlt3722Rev CGATGAATTCCGAGCATGCGGGTTCTCCTG
3722rfpFor CTTAGGTACCCATCGCGCAGTCGTGA
3722rfpRev CGTTGAATTCATGCGGGTTCTCCTGG
Ma2667For CTTAGGTACCAACCGGCTGACTGCGTTCT
Ma2667Rev CGATGAATTCGATCCACGTCCGCTTGAAG
KOsmlt1134-1 ATATTgcatgcCTCTTCACAGGCTTCGATCAGCa
KOsmlt1134-2 CTAGACggtaccCAAGGCACAACGTGTATCTCCCb
KOsmlt1134-3 CCCGGATCggtaccGGTGCGb
KOsmlt1134-4 CTTCTtctagaTGTTGTAGAGGTTGGACCTGTGGc
KOsmlt2852-1 CCTGAgcggccgcCACGTACACCGACAGTTCGd
KOsmlt2852-2 TAGACggtaccATGGGCCATGAACGAGGTGb
KOsmlt2851-3 CATGCggtaccGCATCGCATTGGTGACCGTCb
KOsmlt2851-4 TACCGtctagaGCTTCGATTCCAGCAACTGGGc
KOsmlt3723-1 CCTGAgcggccgcTTGGCAAAGCTGTTCAGCTCCd
KOsmlt3723-2 TAGACggtaccTTCAGTGGCAGGGTAGGGTGb
KOsmlt3723-3 CATGCggtaccGCATGTTCGAGCAGGAACTGGb
KOsmlt3723-4 TACCGtctagaGATCGTGATGGTCTCTCACGACc

aSphI site is shown in lower case letters.

bKpnI site is shown in lower case letters.

cXbaI site is shown in lower case letters.

dNotI site is shown in lower case letters.

The plasmid pUDK018 for deletion of the smlt3723 gene was generated in a similar way. Using the primers KOsmlt3723-1 and KOsmlt3723-2, a 761 bp fragment homologous to the flanking region upstream of smlt3723 was amplified. The PCR product was then digested with NotI and KpnI for ligation into the NotI/KpnI sites of pGPI-SceI-XCm. As a result, the plasmid pUDK017 was obtained. Finally, the deletion plasmid pUDK018 was derived from pUDK017 by amplification of a 660 bp fragment containing the flanking region downstream of smlt3723 with primers KOsmlt3723-3 and KOsmlt3723-4, and cloning of the KpnI/XbaI-digested PCR product into the KpnI/XbaI sites of pUDK017.

The successful construction of all plasmids was verified by DNA sequence analysis of the inserts. The deletion plasmids were transferred to SMK279a by triparental mating as described previously (Aubert et al., 2014), using E. coli DH5α carrying the plasmid pRK2013 as a helper strain, and E. coli SY327/pUDK012, SY327/pUDK015, and SY327/pUDK018 as the donor strains, respectively. Selection for SMK279a co-integrants was performed at 37°C on LB agar plates containing 60 μg/ml chloramphenicol and 5 μg/ml norfloxacin to counter-select against the E. coli helper and donor strains. Streaks of SMK279a exconjugants were subsequently sprayed with 0.45 M pyrocatechol to confirm integration of the deletion plasmids into the genomes of co-integrants. Due to the activity of the pyrocatechol 2,3-dioxygenase encoded by the xylE reporter gene of the deletion plasmids, a bright yellow color of the biomass was indicative of the presence of pUDK012, pUDK015, and pUDK018 in the genomes of the strains, respectively.

As a next step, the plasmid pDAI-SceI-SacB was introduced into the SMK279a co-integrants by triparental mating with DH5α/pRK2013 and DH5α/pDAI-SceI-SacB as helper and donor strains, respectively. Exconjugants were selected at 30°C on LB agar plates containing 50 μg/ml tetracycline and 5 μg/ml norfloxacin, followed by screening for excision of the deletion plasmids. Both the inability of pyrocatechol to turn the color of the exconjugants into bright yellow and sensitivity of the strains to 60 μg/ml chloramphenicol indicated the loss of the integrated plasmids. Finally, the plasmid pDAI-SceI-SacB was cured by sucrose counter-selection as described (Aubert et al., 2014). As a result, the unmarked mutants SMK279aΔsmlt1134, SMK279aΔsmlt2851Δsmlt2852 and SMK279aΔsmlt3723 were obtained. The deleted regions of the mutant strains were verified by PCR and DNA sequence analysis.

The mutant strain SMK279aΔsmlt0387 was generated according to Hoang et al. (1998) and Alavi et al. (2013).

RNA-seq and Data Analysis

To prepare the cell material for RNA-seq analyses, SMK279a was grown on LB agar plates with/without ampicillin (100 μg/ml). Two samples from each colony morphotype (small and big colonies) and two samples from uniform colonies were scrapped from agar plates after 48 h of growth at 37°C, pooled and immediately frozen in liquid nitrogen. About 10–15 mg of wet biomass were generally used for each biological replicate, 10 mg of cell material corresponded to an OD600 of 6.35. Additionally, for RNA extraction of liquid cultures, the strain SMK279a carrying the PblaL2::rfp reporter fusion was grown for 27 and 32 h with 100 μg/ml ampicillin. Total RNA was extracted using the hot-phenol method as described previously (Blomberg et al., 1990). The residual genomic DNA was removed from the total isolated RNA by DNase I treatment. All samples were adjusted to contain equal amounts of extracted RNAs. The cDNA libraries for sequencing were constructed by vertis Biotechnology AG, Germany as described by Sharma et al. (2010). The transcripts were not fragmented. The cDNA libraries were sequenced using a HiSeq 2500 machine (Illumina) in single-read mode and running 100 cycles. To assure a high sequence quality, the Illumina reads in FASTQ format were trimmed with a cut-off phred score of 20 by the program fastq_quality_trimmer from FASTX toolkit version 0.0.131. The alignment of reads, coverage calculation, gene wise read quantification and differential gene expression was performed with READemption (Förstner et al., 2014) version 0.3.5 (doi: 10.5281/zenodo.13926), ‘segemehl’ (Hoffmann et al., 2009) version 0.2.0 and DESeq2 (Love et al., 2014) version 1.6.3. Visual inspection of the coverages was done using the Integrated Genome Browser (IGB; Nicol et al., 2009). The reference sequence for SMK279a was retrieved from the NCBI database (accession no.: NC_010943.1). Genes with a fold-change of ≥2.0 and an adjusted P-value (corrected for multiple testing using the Benjamini–Hochberg procedure) ≤0.05 were considered as differentially expressed. The raw, de-multiplexed reads as well as coverage files have been deposited in the National Center for Biotechnology Information’s Gene Expression Omnibus under the project ID: GSE71735. A shell script that covers the main RNA-Seq data processing steps was deposited at https://zenodo.org/record/34153 (DOI:10.5281/zenodo.34153).

RT-qPCR

Selected differentially regulated genes identified in SMK279a RNA-seq analyses were verified by RT-qPCR experiments as described previously (Krysciak et al., 2014). Gene-specific primers used for RT-qPCR are shown in Table 3. Samples for RNA extraction were taken from colonies that had been grown for 48 h in the presence of ampicillin (100 μg/ml) and were obtained from three independent experiments. The SuperScript® VILOTM cDNA synthesis kit (InvitrogenTM, life technologies, TX, USA) was used to generate cDNA using 1.2 μg RNA. The expression values were normalized against rpoD and 16S rRNA.

Table 3.

Gene-specific primers used for RT-qPCR.

Primer Sequence [5′-3′] Length of amplified product/gene
qsmlt4165-Bfor AAGGGCCTGGAACAGGGCTA 145 bp/rpoD
qsmlt4165-Brev CCACATCCGGCGCAACTTCA
q16S-Afor AGAGTTTGATCCTGGCTCAG 240 bp/16S rRNA
q16S-Arev CTAATCCGACATCGGCTCAT
qsmlt2667-for CGGTCACCTGCTGGACAACA 157 bp/blaL1
qsmlt2667-rev CACCGCCGTTTCTGCATTGG
qsmlt3722-Afor CGTCGCCGATTCCTGCAGTT 144 bp/blaL2
qsmlt3722-Arev TTCCAGCGCGGCGAAATCAC
qsmlt3721-for GAGCCATGAACTGATCTACC 196 bp/smlt3721
qsmlt3721-rev GAACAGGAACAGCGAGGAAA
qsmlt0018-for CGGAACTGGAGTTCACTCTT 168 bp/smlt0018
qsmlt0018-rev TGATGTCCCAATCCGTTAGC
qsmlt0019-for TAATACTAACGGCCCGACCT 205 bp/smlt0019
qsmlt0019-rev TCTTCCTGCACCTGAGTTCT
qsmlt1007-for GAAGGCTTCACCAAGCTCAC 126 bp/smlt1007
qsmlt1007-rev GATGCCGGTCCAGATCGTAT

Genes used for normalization of gene expression.

Whole Genome Sequencing and Variant Detection

Usually a single colony was transferred to fresh LB and cultured overnight to an OD600 of 1.0. Cells were pelleted, and the DNA was isolated with the AquaPure Genomic DNA Kit (Bio-Rad, Hercules, CA, USA). Libraries were generated following the Nextera XT DNA Library Preparation Kit (Illumina, San Diego, CA, USA) and sequenced on the MiSeq (2 × 310 bp) or NextSeq 500 (2 × 151 bp) platform (Illumina, San Diego, CA, USA). Respective FASTQ files were submitted to the EMBL EBI ENA short read archive2 (accession no.: ERP011093). Resulting reads were mapped to the SMK279a genome sequence (accession no.: NC_010943.1) with the alignment program SARUMAN (Blom et al., 2011). All isolates were sequenced with a minimum coverage of 50-fold. For variant detection in mapped reads, we employed customized Perl scripts using a minimum threshold of 10-fold coverage and a minimum allele frequency of 75% (Roetzer et al., 2013). Variant positions were then combined, supplementing the joint list with the respective information from the original mappings. Concatenating all SNP positions with a reliable base call (10-fold coverage and 75% allele frequency) in at least 95% of the isolates and no other SNP within a distance of 12 bp in the same strain yielded a sequence alignment for the construction of a maximum parsimony tree, which was built with the software BioNumerics version 7.5 (Applied Maths, Sint-Martens-Latem, Belgium).

Results

Transient Colony Heterogeneity and Formation of Outer Membrane Vesicles in Response to Antibiotic Treatment

In the absence of antibiotics, the SMK279a wild-type strain forms cream-colored, round and uniform colonies with a diameter of approximately 1.75–2.0 mm after 24 h of growth on LB agar plates at 37°C. Addition of ampicillin (100 μg/ml) resulted in transient colony heterogeneity, with colonies differing in size and appearance (Figure 1) and could be observed as soon as they were visible on the plates. This was usually after 16–18 h of growth at 37°C for big colonies. Small colonies appeared between 24 and 33 h of growth. Colonies were grouped into three categories based on size and origin, i.e., small and big colonies in the presence of ampicillin (Figure 1B) and uniform colonies (Figure 1A) in the absence of ampicillin (Table 4). Formation of different colony morphotypes was independent of the presence or absence of ampicillin in the pre-cultures. When grown in the presence of high concentrations of ampicillin (600 μg/ml), small and big colonies were observed (Figure 1C) and, furthermore, colonies slightly changed the color and appearance (Figure 1D). Among these colonies, some were pointed at the center while others appeared to have a flat colony surface with a wrinkled texture.

FIGURE 1.

FIGURE 1

Phenotypic heterogeneity of SMK279a cells during growth on solid media. (A) SMK279a forms round, uniform colonies when grown without ampicillin on LB agar plates for 48 h at 37°C. (B) Colony heterogeneity on LB agar supplemented with ampicillin showing small and big colonies after growth for 48 h at 37°C. (C) Small colonies (indicated by red dashed circle) and big colonies cultivated on agar plates containing high concentrations of ampicillin (600 μg/ml). (D) Colonies differ slightly in color when cultivated for 48 h on agar plates containing high concentrations of ampicillin (600 μg/ml).

Table 4.

SMK279a colony morphotypes observed after 48 h of growth on LB agar plates with and without ampicillin.

Treatment Concentration [μg/ml] Colony morphotype % of all colonies Colony size [diameter, mm]
Ampicillin 100 Small 80 1.4 ± 0.26
Ampicillin 100 Big 20 3.2 ± 0.27
No ampicillin Uniform 100 3.0 ± 0.06

When we streaked small colonies onto fresh plates without antibiotics, they formed uniform large colonies after overnight incubation, indicating the small colony morphotype was not caused by a genetic mutation. More importantly, small colonies formed both big and small colonies when recultivated in the presence of ampicillin. However, in the presence of ampicillin, cells from big colonies formed again a uniform colony at 24 and 48 h after transfer to fresh agar plates containing ampicillin. This reversible variation in colony morphology was also observed for other strains such as S. maltophilia CF148, an isolate from the respiratory tract of a cystic fibrosis patient, and S. maltophilia DSM-50170 isolated from the human oropharyngeal region (Table 1).

Together with these findings, we observed that cells grown in the presence of ampicillin formed more frequently long bacterial chains (Figure 2). Furthermore, SMK279a cells from both colony morphotypes showed the formation of outer membrane vesicles (OMVs). However, this feature was much more pronounced in the presence of ampicillin (Figures 2B–D) in comparison to cells grown in the absence of the antibiotic that showed only very few or no vesicles (Figure 2A). Intriguingly, the size of the OMVs varied considerably, ranging from less than 100 nm up to 677 nm in diameter in some SMK279a cells, which was twice the size as those reported for other Gram-negative bacteria (Beveridge, 1999). Most likely, these vesicles are packed with blaL1 and blaL2 active enzymes (Devos et al., 2015).

FIGURE 2.

FIGURE 2

Representative scanning electron micrographs (SEM) of SMK279a cells grown in the presence or absence of ampicillin at 37°C for 48 h on LB agar plates. SEM images of SMK279a cells were recorded as previously published (Krohn-Molt et al., 2013). (A) SEM image of cells obtained from colonies cultured in the absence of ampicillin. (B) SEM image of cells obtained from small colonies cultured in the presence of 100 μg/ml ampicillin. (C) SEM image of cells obtained from big colonies cultured in the presence of 100 μg/ml ampicillin. (D) SEM image of cells obtained from big colonies cultured in the presence of 300 μg/ml ampicillin. Cells from (A–C) predominantly formed long filamentous cells (indicated by letter F) and OMVs (indicated by arrows). In the presence of ampicillin, SMK279a cells became enlarged and formed OMVs with sizes up to 677 nm in diameter.

These initial data suggested that the observed colony morphotypes resulted either from gene expression differences at the cellular level within isogenic populations or from heterogeneous expression of resistance genes at a single cell level. Since colony morphotypes were reversible, they most likely were not a result of permanent mutations such as SNPs. To test this hypothesis, we sequenced DNA from 24 individual colonies with diverse morphotypes using NGS technology (Supplementary Figure S1). Overall, we analyzed the genomes of 13 small, 9 big, and 2 uniform colonies with an average 51.4-fold coverage. Compared with the published SMK279a genome sequence, we identified 2–15 SNPs per colony, up to seven deletions and four insertions within all colonies (Supplementary Table S1). Most remarkably, none of these were identified within the known resistome of SMK279a, further supporting the notion that the colony morphotypes were not a primary result of genetic alterations.

A more detailed genome analysis identified SNPs or smaller deletions in 15 genes and ORFs, and none of these appeared to be linked to a gene that is essential for growth (Supplementary Table S2). Only one of the observed SNPs may be linked to β-lactam treatment, namely smlt3885, a gene which codes for a putative UDP-N-acetylmuramate:L-alanyl-gamma-D-glutamyl-meso-diaminopimelate ligase. This enzyme is most likely involved in recycling of cell wall precursors during bacterial cell wall synthesis but is not essential for growth (Mengin-Lecreulx et al., 1996). Two other regions in the SMK279a genome contained high densities of SNPs and indels. These loci are assigned to genes coding for the hypothetical protein Smlt1844B and a two-component regulatory system-sensor histidine kinase (Smlt3944). The smlt1844B and smlt3944 genes carried non-synonymous mutations at seven or nine base positions, respectively (Supplementary Table S2). The product of smlt3944 has a length of 880 amino acids and may be transcribed within an operon with the smlt3943 gene coding for the phosphate-selective porin OprP (Supplementary Figure S2). OprP is mainly expressed under conditions of phosphate starvation (Siehnel et al., 1992), and with the flanking gene smlt3942 (encoding a C4-dicarboxylate transport protein), it is presumably under the regulatory effect of this sensor histidine kinase (Yurgel and Kahn, 2004).

Based on these findings, we concluded that the observed colony heterogeneity is most likely due to reversible genetic switches causing differential gene expression at either a population and/or single cell level.

Differential Gene Expression in Small Versus Big Colonies

The observed colony heterogeneity and differences in cell morphology prompted us to ask the question as to what extent the colony morphotypes would show different transcription profiles at a genome wide level. Therefore, we isolated total RNA from small, big and uniform colonies that were grown at 37°C for 48 h on LB plates. For this purpose, the different colonies were scraped off from the agar plates and pooled to obtain 10–15 mg of cell material for each colony type. We used colonies for RNA extraction as we expected that gene expression profile might reflect a different expression level given the different phenotypes. Given the above observation that the small colonies needed 24–33 h to appear on plates, a harvest at 48 h ensured us sufficient biomass and highly reproducible colony phenotypes for the RNA extraction.

After RNA extraction, cDNA libraries were constructed and sequenced using NGS. For each colony variant, we analyzed two independent biological replicates. Between 7.35 and 12.35 million reads were generated for the two biological replicates and aligned to the reference genome sequence of SMK279a (GenBank: NC_010943.1). The metadata of the samples and RNA-seq analyses are summarized in Table 5.

Table 5.

Overall transcriptome metadata for the analyzed SMK279a colony morphotypes and liquid culture samples.

Sample no. Sample type Sample time point No. of reads generated (×106) No. of uniquely mapped reads (×106)
1 Big colony 48 h 8.80 0.69
2 Big colony 48 h 9.88 0.80
3 Small colony 48 h 9.72 0.63
4 Small colony 48 h 12.35 0.98
5 Uniform colony 48 h 7.35 0.38
6 Uniform colony 48 h 9.60 1.25
7 Liquid culture 27 h 6.30 0.39
8 Liquid culture 27 h 6.90 0.31
9 Liquid culture 32 h 6.84 0.46
10 Liquid culture 32 h 6.85 0.33

For comparative analyses of RNA-seq data, we considered genes with a fold-change of ≥2.0, a Likelihood value ≥0.9 and an adjusted P-value of ≤0.05 as statistically significant and differentially expressed between the colony variants. The RNA-seq data unveiled that isogenic populations of SMK279a cells differentially regulate only a small number of genes between the colony morphotypes. Surprisingly, only 12 genes were significantly and differentially regulated between big and small colony variants (Table 6, Figure 3A). Among the differentially expressed genes, blaL1 (smlt2667) and blaL2 (smlt3722) were 15.3- and 6.9-fold up-regulated in cells forming big colonies in comparison to those forming small colonies, respectively (Table 6, Figure 3B). Upon β-lactam challenge, the transcriptional response in a small colony morphotype further included an altered expression level of genes involved in diverse cellular functions. The level of altered expression of these genes ranged from 2.0 to 3.6-fold, including down-regulation of eight of 14 genes, and up-regulation of six out of the 14 regulated genes (Figure 3B).

Table 6.

Differentially expressed genes for three colony morphotypes in SMK279a.

Locus tag Predicted function Fold-change big vs. small Fold-change big vs. uniform Fold-change small vs. uniform
Smlt0018 Hypothetical protein +7.6 +11.4
Smlt0019 Hypothetical protein +2.2 +3.9
Smlt0706 Fimbria adhesin protein Smf-1 -2.3 -2.0
Smlt0709 Fimbria adhesin protein -2.0
Smlt1735 tRNA delta(2)-isopentenyl pyrophosphate MiaA +2.4
Smlt1766 Hypothetical protein +2.1
Smlt2667 β-lactamase BlaL1 +15.3 +9.9
Smlt2668 Hypothetical protein +5.9 +5.1
Smlt3721 Putative Na+/H+ antiporter AmpH +3.6 +3.5
Smlt3722 β-lactamase BlaL2 +6.9 +7.4
Smlt1844 Modification methylase -2.0
Smlt2601 Poly (beta-D-mannuronate) lyase -2.1
Smlt0003 Hypothetical protein +2.1
Smlt0028 DNA helicase II +2.0
Smlt0044 RHS-repeat-containing protein +2.0
Smlt0201 Hypothetical protein +2.2
Smlt0265 Acyl CoA dehydrogenase -2.1
Smlt0336 Hypothetical protein +2.3
Smlt0353 Transposase +2.0
Smlt0596 Sensor histidine kinase RstB -2.2
Smlt0641 Undecaprenyl-phosphate 4-deoxy-4-formamido-l-arabinose transferase +2.4
Smlt1064 Hypothetical protein +2.8
Smlt1391 Pseudogene +2.1
Smlt1402 Methyl-accepting chemotaxis protein +2.0
Smlt1664 Hypothetical protein +2.6
Smlt1760 Major facilitator super family transmembrane protein - -2.6
Smlt2041 50S ribosomal protein L36 RpmJ +2.0
Smlt3041 Hypothetical protein +2.3
Smlt3056 Transmembrane protein +2.1
Smlt3554 Anti-sigma factor RseA -2.1
Smlt3597 Dehydrogenase -2.1
Smlt4130 Two-component system response regulator AlgR -2.0
Smlt4447A Pseudogene +2.2
Smlt4604 Endonuclease L-PSP family protein +2.0

The table shows genes with a fold-change of ≥2.0, a Likelihood value ≥0.9 and an adjusted P-value of ≤0.05.

FIGURE 3.

FIGURE 3

RNA-seq and RT-qPCR data analysis for different SMK279a colony morphotypes. (A) Scatter plot of fold-change in transcription of genes among cells of big (Y-axis) and small (X-axis) colonies relative to untreated samples of uniform colonies grown in the absence of ampicillin on LB agar plates. A twofold change in the transcription of genes with adjusted P-value of ≤0.05 is considered as significantly, differentially regulated. Cells forming big colonies differentially regulated several genes mainly involved in degradation of antibiotics. The numbers in the plot indicate most strongly regulated genes: 1, smlt0018; 2, smlt2667; 3, smlt3772; 4, smlt2668; 5, smlt0019; 6, smlt3721; 7, smlt1760; and 7, smlt0596. (B) Differentially regulated genes in small colonies in comparison to big and uniform colonies. Down-regulation of blaL1 and blaL2 affected genes involved in regulation, metabolism, virulence, transport and genetic information processing/translation (for details see Table 6). (C) Transcriptome profiles of blaL2 and the flanking genes ampR (smlt3723) and ampH (smlt3721) among the colony morphotypes. The blaL2 gene was 6.9-fold and 7.4-fold down-regulated in cells forming small colonies in comparison to big and uniform colonies, respectively. Transcriptome profile images of the leading strand (indicated in red) and the lagging strand (indicated in blue) were generated with the IGB software (Nicol et al., 2009), merged and rearranged on the leading strand for a simplified visualization. (D) RT-qPCR analysis of genes, which were identified in the RNA-seq data set. Expression profiles of five different genes (blaL2; ampH; blaL1; smlt0019; smlt0018) were obtained from three independent experiments and analyzed based on the normalized gene expression [2-ΔΔC(t) method], using rpoD and 16S rRNA as internal reference genes.

Moreover, as summarized in Table 6, 34 genes were identified to be differentially regulated in small colonies when compared to big and uniform colonies. Thus, four hypothetical proteins (Smlt0018, Smlt0019, Smlt1766, and Smlt2668), a putative Na+/H+ antiporter (Smlt3721, AmpH) and two fimbriae adhesin proteins (Smlt0706, Smf-1, and Smlt0709) are associated with the formation of the different colony morphotype. The fimbrial operon includes smf-1 and smlt0709 and is involved in haemagglutination, biofilm formation, and adherence to cultured mammalian cells (de Oliveira-Garcia et al., 2003). Notably, smlt0018 and smlt0019 most likely form an operon. Furthermore, although ampH is physically linked to blaL2 and the flanking ampR gene (smlt3723; Figure 3C), the function of ampH remains to be determined.

Expression analysis by RT-qPCR was used to confirm the RNA-seq data. We analyzed the expression profiles of five different genes (blaL2; ampH; blaL1; smlt0019; smlt0018) that were differentially transcribed between cells obtained from big and small colonies, including rpoD and 16S rRNA as internal reference genes. We analyzed expression data based on the normalized gene expression (2-ΔΔCT method), and the results confirmed the data obtained by RNA-seq (Figure 3D). The β-lactamase genes blaL1 and blaL2, as well as the putative Na+/H+ antiporter gene ampH were among the strongly upregulated genes in cells forming big colonies.

Since AmpR is the central regulator for the expression of β-lactamases, we analyzed the basal expression of ampR (smlt3723) in big vs. small colony variants. Therefore, we constructed an ampR-deletion mutant. The SMK279aΔsmlt3723 deletion was verified by PCR and whole genome sequencing. Although the SMK279aΔsmlt3723 mutant failed to grow on LB agar plates in the presence of 100 μg/ml ampicillin, it grew well in the absence of any added antibiotic. Therefore, this deletion mutant could not be used to analyze colony morphotypes in the presence of ampicillin.

Heterogeneous Expression of blaL1 and blaL2 in Single Cells

In addition to the observed phenotypic heterogeneity with respect to colony morphologies and OMV formation, we speculated that β-lactamase expression might be subject to heterogeneous expression at a single cell level. To address this hypothesis, we constructed different reporter fusions in the broad host range vector pBBR1MCS-5 (Kovach et al., 1995), using the promoter regions of blaL1 or blaL2 fused to the red (RFP), yellow (YFP), and cyan (CFP) fluorescent proteins (Table 1). All obtained constructs were verified by sequencing and introduced into SMK279a by tri-parental mating using E. coli HB101 with pRK2013 as a helper plasmid (Figurski and Helinski, 1979). In the presence of ampicillin, SMK279a cells grew in long chains during the exponential growth phase rather than in individual rods or aggregates as observed during stationary growth phase. Furthermore, the ampicillin susceptibility of this bacterium was unchanged indicating that the native AmpR binding ligand remained intact and was not affected in trans by the PblaL2::rfp promoter construct (data not shown).

A detailed analysis of single cells by fluorescence microscopy indicated that blaL1 and blaL2 were heterogeneously expressed between individual bacterial cells (Figure 4). In an isogenic culture, we usually detected two stable subpopulations, i.e., individual cells in the bla-ON showing strong fluorescence and those in the bla-OFF mode that display no fluorescence. Noteworthy, individual cells within filaments (or aggregates) of exponentially growing cultures displayed a bla-ON mode, while adjacent cells were in a bla-OFF mode (Figure 4C). This phenomenon was observed in both cells expressing the blaL1 and the blaL2 gene fusion. Further tests in which the promoter of blaL2 was fused to a yellow and cyan fluorescent protein also confirmed heterogeneous expression of the β-lactamase within actively growing cells in the exponential phase (Figures 4D,E; Supplementary Figure S3).

FIGURE 4.

FIGURE 4

Analysis of single cell fluorescence of PblaL1 and PblaL2 promoter gene fusions. (A) Expression of the blaL1 promoter fused to rfp in SMK279a. Cells were grown at 30°C for 17 h under aerobic conditions (200 rpm) in LB medium containing 100 μg/ml ampicillin. Thereby, 2.0 ± 0.72% cells were in the bla-ON and 98.0 ± 0.72% cells were in the bla-OFF mode. (B) Expression of the blaL2 promoter fused to rfp in SMK279a grown under the same conditions as indicated in (A). Here, 4.4 ± 0.69% of cells were in the bla-ON and 95.6 ± 0.69% cells were in the bla-OFF mode. (C) Phenotypic heterogeneity observed in cells (carrying the PblaL2::rfp fusion) forming long cell chains. Cells were grown overnight under aerobic conditions (120 rpm) in LB medium supplemented with 100 μg/ml ampicillin. (D) Phenotypic heterogeneity observed in cells carrying the PblaL2::yfp (E) and the PblaL2::cfp promoter gene fusion. (F) Control cells of SMK279a were grown under the same condition as described in (A) carrying a promoterless rfp reporter fusion (Pless::rfp). Images were recorded with 63x/1.30 Oil M27 and 100x/1.30 Oil M27 lenses using a Zeiss Axio Imager 2 fluorescence microscope (Zeiss, Jena, Germany) and employing appropriate filters.

Additionally, we used SMK279a carrying the native promoter of the ampR-blaL2 intergenic region fused to rfp (PblaL2s::rfp; Table 1). However, cells were in a blaL2-OFF mode indicating the lack of either the promoter recognition or the regulatory region that directs the expression of the reporter protein.

RNA-seq Indicates Few Significantly Differentially Regulated Genes in Homogenous Versus Heterogeneous blaL2-Expressing Cells

Detailed statistical analyses of several hundred cells for each time point during growth in LB medium revealed that the majority (>90%) of the cells were in the blaL2-OFF mode during the first 24 h of growth in 25 ml batch cultures on a shaker (200 rpm). After 32 h, however, the majority of cells expressed the red fluorescent reporter and, thus, was in the blaL2-ON mode (Table 7). This response was independent of the presence of ampicillin. These observations prompted us to analyze the transcriptomes of cells that grew for 27 or 32 h in liquid cultures using RNA-seq. These two time points were selected because growth experiments and single cell counting indicated that less than 5% of all cells were in a blaL2-ON mode after 27 h, whereas more than 90% of all cells were in a blaL2-ON mode after 32 h. Data were analyzed as described above, and the transcriptomic metadata are summarized in Table 5. Two biological replicates were analyzed for each time point. Interestingly, only three genes were differentially expressed between the two time points of 27 and 32 h: smlt2851 and smlt2852, encoding a putative antibiotic resistance transporter and forming an operon, and a putative comE homolog (smlt1134). The smlt2851 and smlt2852 genes were 29- and 7.2-fold up-regulated, respectively, while smlt1134 was 5.4-fold down-regulated at the 32-h sampling time point (Figure 5A). Additional RT-qPCR data supported the observation made for the comE homolog. RT-qPCR indicated a 1.74 ± 0.29-fold down-regulation in the transcription of the smlt1134 gene among cells that were in the blaL2-ON mode vs. blaL2-OFF cells. For the smlt2851 and smlt2852 loci, RT-qPCR data did not confirm the RNA-seq data.

Table 7.

Effects of SMK279a PblaL2::rfp expression at a single cell level.

Assayed SMK279a strain Gene copy added % of cells showing the blaL2-ON mode after 32 h of growth
SMK279a EM2 >90%
SMK279a EM8 comE homolog <1%
SMK279a EM9 smlt2851-smlt2852 >90%
SMK279aΔsmlt1134 >90%
SMK279aΔsmlt2851Δsmlt2852 >90%
SMK279aΔsmlt0387 >90%

Data are mean values of three independent experiments and for each experiment we analyzed a minimum of 400 individual cells.

FIGURE 5.

FIGURE 5

Expression of the comE homolog (smlt1134) under its native promoter. (A) Transcriptome profiles of smlt1134 (black arrow) and flanking genes smlt1133; smlt1135 (gray arrows) in an ‘ON’ state, 32 h (blue) and an ‘OFF’ state, 27 h (red). The comE homolog was found to be 5.4-fold down-regulated in the ‘ON’ state (32 h). Transcriptome profile images of the leading strand and the lagging strand [generated with the IGB software (Nicol et al., 2009)] were merged and rearranged on the leading strand for a simplified visualization. (B) Physical map and orientation of the comE homolog and both putative transporter genes in pBBR1MCS-5. The promoter regions were inserted upstream of PblaL2::rfp, resulting in pBBR1MCS-5::PblaL2::rfp::smlt1134; and pBBR1MCS-5::PblaL2::rfp::smlt2851::smlt2852. The recombinant plasmids were transferred to SMK279a cells and challenged with 100 μg/ml ampicillin. (C) Expression of the comE homolog in SMK279a under its native promoter PComE. Cells were cultivated for 7 h in LB medium supplemented with 100 μg/ml ampicillin. Expression of comE clearly affects blaL2 heterogeneous expression resulting in non-fluorescing cells (blaL2-OFF mode), here less than 1% of cells were in the bla-ON mode. Right and left panels are a bright-field and a fluorescence microscopic image, respectively. (D) Expression of both putative transporter genes (smlt2851; smlt2852) in SMK279a under their native promoter P2851/2852. Expression of the transporter genes did not alter phenotypic heterogeneous expression of the blaL2 gene. Here, 5.5 ± 2.12% of the cells were in the bla-ON and 94.5 ± 2.12% cells were in the bla-OFF mode. Cells were cultured under the same condition as indicated in (C). Right and left panels are a bright-field and a fluorescence microscopic image, respectively. Images (C) and (D) were recorded as described in Figure 4.

To analyze the impact of Smlt2851, Smlt2852, and Smlt1134 (ComE homolog) on phenotypic heterogeneous blaL2 expression, the genes were overexpressed in SMK279a. The respective operons and predicted promoter regions were PCR amplified and inserted upstream of PblaL2::rfp in pBBR1MCS-5, resulting in pBBR1MCS-5::PblaL2::rfp::smlt1134; and pBBR1MCS-5::PblaL2::rfp::smlt2851::smlt2852 (Figure 5B). The recombinant plasmids were transferred to SMK279a cells and challenged with 100 μg/ml ampicillin. Only the overexpression of the comE homolog in SMK279a resulted in an altered transcriptomic profile with respect to phenotypic heterogeneity at a single cell level (Figure 5C; Table 7). The expression of extra copies of the comE homolog in SMK279a reduced the frequency of blaL2-ON cells to 1 % or lower after 32 h of growth. The overexpression of both putative transporter genes (smlt2851; smlt2852) under their native promoter did not alter phenotypic heterogeneous expression of the blaL2 gene (Figure 5D). In corresponding control sets, usually >90% of all cells were in a blaL2-ON mode (Table 7).

Furthermore, we constructed deletion mutants of both loci, smlt1134 (comE homolog) and smlt2851smlt2852 (Supplementary Figure S4). However, phenotypic heterogeneous gene expression of the blaL2 reporter fusion was not altered in the background of any of these deletion mutants, suggesting that the lack of expression is not linked to heterogeneous expression. Furthermore, the use of a deletion mutant strain with a mutation in the smlt0387 gene (ax21 homolog) did not show phenotypic heterogeneity (Table 7). The Ax21 peptide was suggested to act as a cell–cell signal to regulate a diverse range of functions, including virulence, in Stenotrophomonas (McCarthy et al., 2011). Taken together, the data indicate that the ComE homolog appears to be involved in the regulation of phenotypic heterogeneity of blaL2 gene expression in S. maltophilia.

Disussion

Stenotrophomonas maltophilia encodes in its genome for two β-lactamases, L1 and L2. Expression of both β-lactamases is mainly controlled through the function of the master regulator AmpR in the presence of β-lactam antibiotics. The activity of AmpR is modulated via its activator (anhydro-MurNAc-oligopeptide) and repressor (UDP-MurNAc-oligopeptide) ligands (Dietz et al., 1997; Jacobs et al., 1997; Balcewich et al., 2010). Here we provide the first evidence, that beside these well-known regulatory elements, phenotypic heterogeneity plays a crucial role in β-lactamase gene expression and has profound effects on colony morphotypes. Non-genetically determined phenotypic heterogeneity has been observed in many bacteria as extensively reviewed (Ackermann, 2015; Grote et al., 2015). Well-studied systems with respect to phenotypic heterogeneity include the phenomenon of persister cells, activation of autoinducer synthase genes, flagella biosynthesis, and others (Anetzberger et al., 2009; Deris et al., 2013; Mulder and Coombes, 2013; Grote et al., 2014; Wang et al., 2014). The term ‘phenotypic heterogeneity’ thereby describes the more general phenomenon of heterogeneous behavior within isogenic cultures and is often linked with the term ‘bet-hedging’, which describes the evolutionary strategy for phenotypic heterogeneity.

The data presented in this study imply that SMK279a forms phenotypic heterogeneous subpopulations with respect to the expression of both β-lactamase genes. Two lines of evidence support this hypothesis. Firstly, cells from small and big colony variants differ mainly in the expression of 12 genes, with both β-lactamase genes blaL1 and the blaL2 being among the strongest differentially regulated genes between the two different colony morphotypes (Table 6). Several distinct expression patterns were stable enough to allow differentiation into different colony morphotypes. SEM analyses further revealed that many cells rather grew as long cell chains and produced OMVs in response to β-lactam treatment (Figures 2B,C). This phenomenon, however, was only observed in part of the populations. A second line of evidence resulted from data obtained with promoter fusions of the blaL1 and blaL2 genes. High levels of heterogeneous β-lactamase expression were observed in liquid cultures. Although, the overall number of cells that were in an ON mode varied between the different promoter fusions, they all shared the common feature of heterogeneous blaL1 and blaL2 expression (Figures 4A–E). Indeed, a weak and constitutive expression of the blaL1 and blaL2 genes was present in untreated cells that were grown in an environment free of stressful antibiotic challenges.

Furthermore, genome-wide sequence analysis of 24 colony variants identified a significant number of SNPs. The majority of SNPs were affiliated with genes encoding the two-component regulatory system-sensor histidine kinase Smlt3944 and the hypothetical protein Smlt1844B (Supplementary Tables S2 and S3). Remarkably, none of the SNPs were observed in any of hitherto known genes that are part of the SMK279a resistome. These data imply that the colony morphotypes were indeed a result of heterogeneous behavior within a syngeneic bacterial population mainly involving genetic switches during alternations from one state to another. Furthermore, this phenotypic diversity is reversible but not based on β-lactam induced mutagenesis, since mutagenesis in bacteria has been shown to be only caused by sub-inhibitory concentration of β-lactams (Gutierrez Rodero et al., 1996). Our study also revealed that the phenotypic heterogeneity described inhere differs from previously described small colony variants (SCVs) isolated for many pathogens, including S. maltophilia (Proctor et al., 2006; Anderson et al., 2007). SCVs represent a subpuplation of slow-growing bacteria with growth characteristics and morphotypes distinct from those of the wild-type counterparts. Our data further indicate that ComE is part of a network involved in the regulation of phenotypic heterogeneity in SMK279a. Consequently, overexpression of the comE homolog resulted in a decreased heterogeneity of blaL2 expression. The comE gene codes for a DNA-binding protein that has been identified previously as part of a regulatory cascade responsible for bacterial heterogeneity in the Gram-positive bacterium Streptococcus pneumoniae (Johnsborg and Havarstein, 2009). It is noteworthy that ComE contains a helix-hairpin-helix (HhH) motif, which is mainly involved in non-sequence-specific DNA-binding (Shao and Grishin, 2000). Thereby, post-transcriptional regulation of the comE gene involves in part the RNA-binding protein (Hfq) that regulates a wide variety of cellular responses via interacting with small RNAs (sRNAs) and mRNAs (Roscetto et al., 2012), indicating the complex network for comE regulation and its diverse roles in cells. Within this framework, comE might also be involved in regulating phenotypic heterogeneity with respect to the blaL2 gene expression (Figure 5C, Table 7). Finally, it is important to consider that the underlying mechanism for modulating phenotypic heterogeneity is complex, involving in some cases several genes from the regulatory circuit (Morand and Mühlemann, 2007).

In summary, phenotypic heterogeneity affects β-lactamase expression in SMK279a. We speculate that phenotypic heterogeneity in SMK279a cells provides a selective advantage in natural environments and during the infection of human epithelia to respond against antimicrobial effectors. This adaptation is probably also relevant during acute and chronic human infections associated with S. maltophilia and effectiveness of antibiotic treatment. Future work will identify the underlying molecular switches involved in triggering phenotypic heterogeneity in S. maltophilia.

Author Contributions

EA is the contributing author. EA, DK and WRS wrote and edited the manuscript. UM provided mutants and edited the manuscript. TK and SN provided the SNP analyses; KF provided the RNA-seq data; IK-M, CS, US also contributed to this research and manuscript.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

EA was supported by a grant from the German Academic Exchange program (DAAD). Part of this work were funded through the DFG grant STR451/7-1 within the priority program SPP1617, by the EU FP7 Patho-Ngen-Trace (FP7- 278864-2) project, and by in house funding of the Research Center Borstel. We thank Dörte Grella and Manuel Hein (Research Center Borstel) for technical assistance as well as Julia Zallet and Tanja Ubben for their help with library preparation and sequencing. The authors are grateful to Miguel A. Valvano (Center for Infection and Immunity, Queen’s University, Belfast, UK) for providing the pGPI-SceI/pDAI-SceI-SacB system.

Footnotes

Supplementary Material

The Supplementary Material for this article can be found online at: http://journal.frontiersin.org/article/10.3389/fmicb.2015.01373

References

  1. Ackermann M. (2015). A functional perspective on phenotypic heterogeneity in microorganisms. Nat. Rev. Microbiol. 13 497–508. 10.1038/nrmicro3491 [DOI] [PubMed] [Google Scholar]
  2. Agger W. A., Cogbill T. H., Busch H., Jr., Landercasper J., Callister S. M. (1986). Wounds caused by corn-harvesting machines: an unusual source of infection due to gram-negative bacilli. Rev. Infect. Dis. 8 927–931. 10.1093/clinids/8.6.927 [DOI] [PubMed] [Google Scholar]
  3. Al Naiemi N., Duim B., Bart A. (2006). A CTX-M extended-spectrum beta-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J. Med. Microbiol. 55 1607–1608. 10.1099/jmm.0.46704-0 [DOI] [PubMed] [Google Scholar]
  4. Alavi P., Muller H., Cardinale M., Zachow C., Sanchez M. B., Martinez J. L., et al. (2013). The DSF quorum sensing system controls the positive influence of Stenotrophomonas maltophilia on plants. PLoS ONE 8:e67103 10.1371/journal.pone.0067103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Al-Hilali N., Nampoory M. R., Johny K. V., Chugh T. D. (2000). Xanthomonas maltophilia infection in chronic peritoneal dialysis patients. Scand. J. Urol. Nephrol. 34 67–69. [DOI] [PubMed] [Google Scholar]
  6. Amato S. M., Fazen C. H., Henry T. C., Mok W. W. K., Orman M. A., Sandvik E. L., et al. (2014). The role of metabolism in bacterial persistence. Front. Microbiol. 5:70 10.3389/fmicb.2014.00070 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Anderson S. W., Stapp J. R., Burns J. L., Qin X. (2007). Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis. J. Clin. Microbiol. 45 529–535. 10.1128/JCM.01444-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Anetzberger C., Pirch T., Jung K. (2009). Heterogeneity in quorum sensing-regulated bioluminescence of Vibrio harveyi. Mol. Microbiol. 73 267–277. 10.1111/j.1365-2958.2009.06768.x [DOI] [PubMed] [Google Scholar]
  9. Aubert D., Hamad M., Valvano M. (2014). “A markerless deletion method for genetic manipulation of burkholderia cenocepacia and other multidrug-resistant gram-negative bacteria,” in Host-Bacteria Interactions, eds Vergunst A. C., O’Callaghan D. (New York, NY: Springer; ), 311–327. [DOI] [PubMed] [Google Scholar]
  10. Avison M. B., Higgins C. S., Ford P. J., von Heldreich C. J., Walsh T. R., Bennett P. M. (2002). Differential regulation of L1 and L2 beta-lactamase expression in Stenotrophomonas maltophilia. J. Antimicrob Chemother. 49 387–389. 10.1093/jac/49.2.387 [DOI] [PubMed] [Google Scholar]
  11. Avison M. B., von Heldreich C. J., Higgins C. S., Bennett P. M., Walsh T. R. (2000). A TEM-2beta-lactamase encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 46 879–884. 10.1093/jac/46.6.879 [DOI] [PubMed] [Google Scholar]
  12. Baird G. S., Zacharias D. A., Tsien R. Y. (2000). Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral. Proc. Natl. Acad. Sci. U.S.A. 97 11984–11989. 10.1073/pnas.97.22.11984 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Balcewich M. D., Reeve T. M., Orlikow E. A., Donald L. J., Vocadlo D. J., Mark B. L. (2010). Crystal structure of the ampr effector binding domain provides insight into the molecular regulation of inducible AmpC β-Lactamase. J. Mol. Biol. 400 998–1010. 10.1016/j.jmb.2010.05.040 [DOI] [PubMed] [Google Scholar]
  14. Beveridge T. J. (1999). Structures of gram-negative cell walls and their derived membrane vesicles. J. Bacteriol. 181 4725–4733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Blom J., Jakobi T., Doppmeier D., Jaenicke S., Kalinowski J., Stoye J., et al. (2011). Exact and complete short-read alignment to microbial genomes using Graphics Processing Unit programming. Bioinformatics 27 1351–1358. 10.1093/bioinformatics/btr151 [DOI] [PubMed] [Google Scholar]
  16. Blomberg P., Wagner E. G., Nordstrom K. (1990). Control of replication of plasmid R1: the duplex between the antisense RNA, CopA, and its target, CopT, is processed specifically in vivo and in vitro by RNase III. EMBO J. 9 2331–2340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Brooke J. S. (2012). Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin. Microbiol. Rev. 25 2–41. 10.1128/CMR.00019-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Crossman L., Gould V., Dow J. M., Vernikos G., Okazaki A., Sebaihia M., et al. (2008). The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 9:R74 10.1186/gb-2008-9-4-r74 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Cullmann W., Dick W. (1990). Heterogeneity of beta-lactamase production in Pseudomonas maltophilia, a nosocomial pathogen. Chemotherapy 36 117–126. 10.1159/000238757 [DOI] [PubMed] [Google Scholar]
  20. Davidson C. J., Surette M. G. (2008). Individuality in bacteria. Annu. Rev. Genet. 42 253–268. 10.1146/annurev.genet.42.110807.091601 [DOI] [PubMed] [Google Scholar]
  21. de Oliveira-Garcia D., Dall’Agnol M., Rosales M., Azzuz A. C., Alcantara N., Martinez M. B., et al. (2003). Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces. Cell Microbiol. 5 625–636. 10.1046/j.1462-5822.2003.00306.x [DOI] [PubMed] [Google Scholar]
  22. Denton M., Kerr K. G. (1998). Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin. Microbiol. Rev. 11 57–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Deris J. B., Kim M., Zhang Z., Okano H., Hermsen R., Groisman A., et al. (2013). The innate growth bistability and fitness landscapes of antibiotic-resistant bacteria. Science 342 1237435-1–1237435-9. 10.1126/science.1237435 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Devos S., Van Oudenhove L., Stremersch S., Van Putte W., Derycke R., Van Driessche G., et al. (2015). The effect of imipenem and diffusible signaling factors on the secretion of outer membrane vesicles and associated Ax21 proteins in Stenotrophomonas maltophilia. Front. Microbiol. 6:298 10.3389/fmicb.2015.00298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Dietz H., Pfeifle D., Wiedemann B. (1997). The signal molecule for beta-lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide. Antimicrob. Agents Chemother. 41 2113–2120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Elsner H. A., Duhrsen U., Hollwitz B., Kaulfers P. M., Hossfeld D. K. (1997). Fatal pulmonary hemorrhage in patients with acute leukemia and fulminant pneumonia caused by Stenotrophomonas maltophilia. Ann. Hematol. 74 155–161. 10.1007/s002770050275 [DOI] [PubMed] [Google Scholar]
  27. Elting L. S., Bodey G. P. (1990). Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine (Baltimore) 69 296–306. 10.1097/00005792-199009000-00003 [DOI] [PubMed] [Google Scholar]
  28. Figurski D. H., Helinski D. R. (1979). Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc. Natl. Acad. Sci. U.S.A. 76 1648–1652. 10.1073/pnas.76.4.1648 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Flannagan R. S., Linn T., Valvano M. A. (2008). A system for the construction of targeted unmarked gene deletions in the genus Burkholderia. Environ. Microbiol. 10 1652–1660. 10.1111/j.1462-2920.2008.01576.x [DOI] [PubMed] [Google Scholar]
  30. Förstner K. U., Vogel J., Sharma C. M. (2014). READemption – a tool for the computational analysis of deep-sequencing-based transcriptome data. Bioinformatics 30 3421–3423. 10.1093/bioinformatics/btu533 [DOI] [PubMed] [Google Scholar]
  31. Gould V. C., Okazaki A., Avison M. B. (2006). Beta-lactam resistance and beta-lactamase expression in clinical Stenotrophomonas maltophilia isolates having defined phylogenetic relationships. J. Antimicrob. Chemother. 57 199–203. 10.1093/jac/dki453 [DOI] [PubMed] [Google Scholar]
  32. Grote J., Krysciak D., Schorn A., Dahlke R. I., Soonvald L., Muller J., et al. (2014). Evidence of autoinducer-dependent and -independent heterogeneous gene expression in Sinorhizobium fredii NGR234. Appl. Environ. Microbiol. 80 5572–5582. 10.1128/AEM.01689-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Grote J., Krysciak D., Streit W. R. (2015). Phenotypic heterogeneity, a phenomenon that may explain why quorum sensing not always results in truly homogenous cell behavior. Appl. Environ. Microbiol. 81 5280–5289. 10.1128/AEM.00900-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Gutierrez Rodero F., Masia M. M., Cortes J., Ortiz de la Tabla V., Mainar V., Vilar A. (1996). Endocarditis caused by Stenotrophomonas maltophilia: case report and review. Clin. Infect. Dis. 23 1261–1265. 10.1093/clinids/23.6.1261 [DOI] [PubMed] [Google Scholar]
  35. Hamad M. A., Skeldon A. M., Valvano M. A. (2010). Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay. Appl. Environ. Microbiol. 76 3170–3176. 10.1128/AEM.03024-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Hanahan D. (1983). Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166 557–580. 10.1016/S0022-2836(83)80284-8 [DOI] [PubMed] [Google Scholar]
  37. Helaine S., Kugelberg E. (2014). Bacterial persisters: formation, eradication, and experimental systems. Trends Microbiol. 22 417–424. 10.1016/j.tim.2014.03.008 [DOI] [PubMed] [Google Scholar]
  38. Henderson I., Owen P. (1999). The major phase-variable outer membrane protein of Escherichia coli structurally resembles the immunoglobulin A1 protease class of exported protein and is regulated by a novel mechanism involving Dam and oxyR. J. Bacteriol. 181 2132–2141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Hoang T. T., Karkhoff-Schweizer R. R., Kutchma A. J., Schweizer H. P. (1998). A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212 77–86. 10.1016/S0378-1119(98)00130-9 [DOI] [PubMed] [Google Scholar]
  40. Hoffmann S., Otto C., Kurtz S., Sharma C. M., Khaitovich P., Vogel J., et al. (2009). Fast mapping of short sequences with mismatches. Insertions and deletions using index structures. PLoS Comput. Biol. 5:e1000502 10.1371/journal.pcbi.1000502 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Hu R.-M., Huang K.-J., Wu L.-T., Hsiao Y.-J., Yang T.-C. (2008). Induction of L1 and L2 β-Lactamases of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 52 1198–1200. 10.1128/AAC.00682-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Jacobs C., Frere J. M., Normark S. (1997). Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in gram-negative bacteria. Cell 88 823–832. 10.1016/S0092-8674(00)81928-5 [DOI] [PubMed] [Google Scholar]
  43. Johnsborg O., Havarstein L. S. (2009). Regulation of natural genetic transformation and acquisition of transforming DNA in Streptococcus pneumoniae. FEMS Microbiol. Rev. 33 627–642. 10.1111/j.1574-6976.2009.00167.x [DOI] [PubMed] [Google Scholar]
  44. Kaern M., Elston T. C., Blake W. J., Collins J. J. (2005). Stochasticity in gene expression: from theories to phenotypes. Nat. Rev. Genet. 6 451–464. 10.1038/nrg1615 [DOI] [PubMed] [Google Scholar]
  45. Keren I., Shah D., Spoering A., Kaldalu N., Lewis K. (2004). Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186 8172–8180. 10.1128/jb.186.24.8172-8180.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Kovach M. E., Elzer P. H., Hill D. S., Robertson G. T., Farris M. A., Roop R. M., II, et al. (1995). Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene 166 175–176. 10.1016/0378-1119(95)00584-1 [DOI] [PubMed] [Google Scholar]
  47. Krohn-Molt I., Wemheuer B., Alawi M., Poehlein A., Gullert S., Schmeisser C., et al. (2013). Metagenome survey of a multispecies and alga-associated biofilm revealed key elements of bacterial-algal interactions in photobioreactors. Appl. Environ. Microbiol. 79 6196–6206. 10.1128/AEM.01641-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Krysciak D., Grote J., Rodriguez Orbegoso M., Utpatel C., Forstner K. U., Li L., et al. (2014). RNA sequencing analysis of the broad-host-range strain Sinorhizobium fredii NGR234 identifies a large set of genes linked to quorum sensing-dependent regulation in the background of a traI and ngrI deletion mutant. Appl. Environ. Microbiol. 80 5655–5671. 10.1128/AEM.01835-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Lewis K. (2007). Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5 48–56. 10.1038/nrmicro1557 [DOI] [PubMed] [Google Scholar]
  50. Lewis K. (2010). Persister cells. Annu. Rev. Microbiol. 64 357–372. 10.1146/annurev.micro.112408.134306 [DOI] [PubMed] [Google Scholar]
  51. Lin C. W., Huang Y. W., Hu R. M., Chiang K. H., Yang T. C. (2009). The role of AmpR in regulation of L1 and L2 beta-lactamases in Stenotrophomonas maltophilia. Res. Microbiol. 160 152–158. 10.1016/j.resmic.2008.11.001 [DOI] [PubMed] [Google Scholar]
  52. Love M. I., Huber W., Anders S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15:550 10.1186/s13059-014-0550-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Magdanova L. A., Golyasnaya N. V. (2013). Heterogeneity as an adaptive trait of microbial populations. Microbiology 82 1–10. 10.1134/S0026261713010074 [DOI] [PubMed] [Google Scholar]
  54. Maisonneuve E., Castro-Camargo M., Gerdes K. (2013). (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell 154 1140–1150. 10.1016/j.cell.2013.07.048 [DOI] [PubMed] [Google Scholar]
  55. Maisonneuve E., Gerdes K. (2014). Molecular mechanisms underlying bacterial persisters. Cell 157 539–548. 10.1016/j.cell.2014.02.050 [DOI] [PubMed] [Google Scholar]
  56. McCarthy Y., Dow J. M., Ryan R. P. (2011). The Ax21 Protein Is a Cell-Cell Signal That regulates virulence in the nosocomial pathogen Stenotrophomonas maltophilia. J. Bacteriol. 193 6375–6378. 10.1128/JB.05949-11 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  57. Mengin-Lecreulx D., van Heijenoort J., Park J. T. (1996). Identification of the mpl gene encoding UDP-N-acetylmuramate: L-alanyl-gamma-D-glutamyl-meso-diaminopimelate ligase in Escherichia coli and its role in recycling of cell wall peptidoglycan. J. Bacteriol. 178 5347–5352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Miller V. L., Mekalanos J. J. (1988). A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J. Bacteriol. 170 2575–2583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Morand B., Mühlemann K. (2007). Heteroresistance to penicillin in Streptococcus pneumoniae. Proc. Natl. Acad. Sci. U.S.A. 104 14098–14103. 10.1073/pnas.0702377104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Mulder D. T., Coombes B. K. (2013). Infection biology: cheats never prosper. Nature 494 321–322. 10.1038/494321a [DOI] [PubMed] [Google Scholar]
  61. Nguyen M. H., Muder R. R. (1994). Meningitis due to Xanthomonas maltophilia: case report and review. Clin. Infect. Dis. 19 325–326. 10.1093/clinids/19.2.325 [DOI] [PubMed] [Google Scholar]
  62. Nicol J. W., Helt G. A., Blanchard S. G., Raja A., Loraine A. E. (2009). The integrated genome browser: free software for distribution and exploration of genome-scale datasets. Bioinformatics 25 2730–2731. 10.1093/bioinformatics/btp472 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Okazaki A., Avison M. B. (2008). Induction of L1 and L2 β-Lactamase Production in Stenotrophomonas maltophilia Is Dependent on an AmpR-Type Regulator. Antimicrob. Agents Chemother. 52 1525–1528. 10.1128/AAC.01485-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Proctor R. A., von Eiff C., Kahl B. C., Becker K., McNamara P., Herrmann M., et al. (2006). Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 4 295–305. 10.1038/nrmicro1384 [DOI] [PubMed] [Google Scholar]
  65. Rangannan V., Bansal M. (2011). PromBase: a web resource for various genomic features and predicted promoters in prokaryotic genomes. BMC Res. Notes 4:257 10.1186/1756-0500-4-257 [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Rizzo M. A., Springer G. H., Granada B., Piston D. W. (2004). An improved cyan fluorescent protein variant useful for FRET. Nat. Biotechnol. 22 445–449. 10.1038/nbt945 [DOI] [PubMed] [Google Scholar]
  67. Roetzer A., Diel R., Kohl T. A., Rückert C., Nübel U., Blom J., et al. (2013). Whole Genome Sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis Outbreak: a longitudinal molecular epidemiological study. PLoS Med. 10:e1001387 10.1371/journal.pmed.1001387 [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Roscetto E., Angrisano T., Costa V., Casalino M., Forstner K. U., Sharma C. M., et al. (2012). Functional characterization of the RNA chaperone Hfq in the opportunistic human pathogen Stenotrophomonas maltophilia. J. Bacteriol. 194 5864–5874. 10.1128/JB.00746-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Ryan R. P., Monchy S., Cardinale M., Taghavi S., Crossman L., Avison M. B., et al. (2009). The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat. Rev. Microbiol. 7 514–525. 10.1038/nrmicro2163 [DOI] [PubMed] [Google Scholar]
  70. Saino Y., Kobayashi F., Inoue M., Mitsuhashi S. (1982). Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia. Antimicrob. Agents Chemother. 22 564–570. 10.1128/AAC.22.4.564 [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Shaner N. C., Campbell R. E., Steinbach P. A., Giepmans B. N., Palmer A. E., Tsien R. Y. (2004). Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol. 22 1567–1572. 10.1038/nbt1037 [DOI] [PubMed] [Google Scholar]
  72. Shao X., Grishin N. V. (2000). Common fold in helix–hairpin–helix proteins. Nucleic Acids Res. 28 2643–2650. 10.1093/nar/28.14.2643 [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Shapiro J. A. (1998). Thinking about bacterial populations as multicellular organisms. Annu. Rev. Microbiol. 52 81–104. 10.1146/annurev.micro.52.1.81 [DOI] [PubMed] [Google Scholar]
  74. Sharma C. M., Hoffmann S., Darfeuille F., Reignier J., Findeisz S., Sittka A., et al. (2010). The primary transcriptome of the major human pathogen Helicobacter pylori. Nature 464 250–255. 10.1038/nature08756 [DOI] [PubMed] [Google Scholar]
  75. Siehnel R. J., Egli C., Hancock R. E. (1992). Polyphosphate-selective porin OprO of Pseudomonas aeruginosa: expression, purification and sequence. Mol. Microbiol. 6 2319–2326. 10.1111/j.1365-2958.1992.tb01407.x [DOI] [PubMed] [Google Scholar]
  76. Tipton K. A., Dimitrova D., Rather P. N. (2015). Phase-variable control of multiple phenotypes in Acinetobacter baumannii strain AB5075. J. Bacteriol. 197 2593–2599. 10.1128/JB.00188-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Typas A., Banzhaf M., Gross C. A., Vollmer W. (2012). From the regulation of peptidoglycan synthesis to bacterial growth and morphology. Nat. Rev. Microbiol. 10 123–136. 10.1038/nrmicro2677 [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Walsh T. R., Hall L., Assinder S. J., Nichols W. W., Cartwright S. J., MacGowan A. P., et al. (1994). Sequence analysis of the L1 metallo-beta-lactamase from Xanthomonas maltophilia. Biochim. Biophys. Acta 1218 199–201. 10.1016/0167-4781(94)90011-6 [DOI] [PubMed] [Google Scholar]
  79. Walsh T. R., MacGowan A. P., Bennett P. M. (1997). Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 41 1460–1464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Wang X., Kang Y., Luo C., Zhao T., Liu L., Jiang X., et al. (2014). Heteroresistance at the single-cell level: adapting to antibiotic stress through a population-based strategy and growth-controlled interphenotypic coordination. MBio 5:e942 10.1128/mBio.00942-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Wu N., He L., Cui P., Wang W., Yuan Y., Liu S., et al. (2015). Ranking of persister genes in the same Escherichia coli genetic background demonstrates varying importance of individual persister genes in tolerance to different antibiotics. Front. Microbiol. 6:1003 10.3389/fmicb.2015.01003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Yurgel S. N., Kahn M. L. (2004). Dicarboxylate transport by rhizobia. FEMS Microbiol. Rev. 4 489–501. 10.1016/j.femsre.2004.04.002 [DOI] [PubMed] [Google Scholar]
  83. Zeng X., Lin J. (2013). Beta-lactamase induction and cell wall metabolism in Gram-negative bacteria. Front. Microbiol. 4:128 10.3389/fmicb.2013.00128 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES